Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (Tables)

v3.8.0.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2017
Stockholders' Equity Note [Abstract]  
Schedule of warrants outstanding at various exercise prices
The warrants had various exercise prices and terms as follows:
 
 
 
Warrants
 
Exercise
 
Expiration
 
Summary of Warrants
 
Outstanding
 
Price
 
Date
 
2015 Financing 7/31/15 (a)
 
 
20,000
 
$
6.05
 
 
07/31/20
 
2015 Financing 5/11/15 agent warrants (b)
 
 
50,000
 
 
11.00
 
 
5/11/20
 
2014 Financing 12/24/14 (c)
 
 
2,395,949
 
 
5.00
 
 
12/24/19
 
2014 Financing 12/24/14 agent warrants (c)
 
 
68,735
 
 
5.00
 
 
12/18/19
 
2012 Series B private placement (d)
 
 
400,001
 
 
25.00
 
 
10/24/18
 
Total
 
 
2,934,685
 
 
 
 
 
 
 
 
a)
In connection with the offering on July 31, 2015, the placement agent received warrants to purchase 20,000 share of common stock at $6.05 per share. The warrants are exercisable and expire on July 31, 2020.
 
b)
In connection with the offering on May 11, 2015, the placement agent received warrants to purchase 50,000 share of common stock at $11.00 per share. The warrants are exercisable and expire on May 11, 2020.
 
c)
In connection with an offering on December 24, 2014, warrants to purchase 3,500,000 shares of common stock at $5.00 per share were purchased and issued for $0.01 per warrant. All of the warrants are exercisable and expire on December 24, 2019. At December 31, 2017, 2,395,949 warrants are outstanding.
 
Also in connection with the offering on December 24, 2014, the underwriter received warrants to purchase 68,735 shares of common stock at $5.00 per share. The warrants are exercisable and expire on December 18, 2019.
 
d)
In connection with a private placement offering on October 25, 2012, warrants to purchase 400,001 shares of common stock at $25.00 per share were issued. All of the warrants are exercisable and expire on October 24, 2018.